Westpac Banking Corp Has $260,000 Stock Position in Church & Dwight Co., Inc. (NYSE:CHD)

Westpac Banking Corp lowered its holdings in Church & Dwight Co., Inc. (NYSE:CHD) by 88.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,595 shares of the company’s stock after selling 20,655 shares during the quarter. Westpac Banking Corp’s holdings in Church & Dwight were worth $260,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Clarius Group LLC grew its holdings in Church & Dwight by 7.4% in the 2nd quarter. Clarius Group LLC now owns 2,857 shares of the company’s stock valued at $286,000 after buying an additional 197 shares during the last quarter. Trillium Asset Management LLC grew its holdings in Church & Dwight by 1.5% in the 2nd quarter. Trillium Asset Management LLC now owns 39,775 shares of the company’s stock valued at $3,987,000 after buying an additional 580 shares during the last quarter. Checchi Capital Advisers LLC acquired a new stake in Church & Dwight in the 2nd quarter valued at approximately $220,000. Charles Schwab Investment Management Inc. grew its holdings in Church & Dwight by 0.6% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 1,298,382 shares of the company’s stock valued at $130,137,000 after buying an additional 8,058 shares during the last quarter. Finally, Oxler Private Wealth LLC lifted its position in shares of Church & Dwight by 0.9% in the 2nd quarter. Oxler Private Wealth LLC now owns 34,096 shares of the company’s stock worth $3,418,000 after acquiring an additional 294 shares during the period. Institutional investors and hedge funds own 82.79% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on CHD shares. Barclays reduced their price objective on Church & Dwight from $82.00 to $76.00 and set an “underweight” rating for the company in a research report on Thursday, October 12th. Stifel Nicolaus raised their price objective on Church & Dwight from $95.00 to $97.00 and gave the stock a “hold” rating in a research report on Monday, July 31st. Citigroup reduced their price objective on Church & Dwight from $105.00 to $94.00 and set a “neutral” rating for the company in a research report on Wednesday, October 11th. TheStreet downgraded Church & Dwight from a “b-” rating to a “c” rating in a research report on Friday, November 3rd. Finally, Raymond James upgraded Church & Dwight from an “underperform” rating to a “market perform” rating in a research report on Monday, October 23rd. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, Church & Dwight presently has a consensus rating of “Hold” and a consensus target price of $95.25.

Insider Activity

In other news, CEO Matthew Farrell sold 132,881 shares of Church & Dwight stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $96.00, for a total value of $12,756,576.00. Following the completion of the sale, the chief executive officer now directly owns 112,444 shares of the company’s stock, valued at approximately $10,794,624. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 2.00% of the company’s stock.

Church & Dwight Trading Down 0.5 %

Shares of CHD opened at $92.40 on Friday. The stock has a fifty day moving average price of $91.23 and a two-hundred day moving average price of $94.27. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.90 and a current ratio of 1.47. Church & Dwight Co., Inc. has a 52-week low of $75.86 and a 52-week high of $100.52. The company has a market cap of $22.77 billion, a price-to-earnings ratio of 52.80, a PEG ratio of 3.78 and a beta of 0.50.

Church & Dwight (NYSE:CHD) last issued its quarterly earnings data on Friday, November 3rd. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.68 by $0.06. The firm had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.44 billion. Church & Dwight had a return on equity of 20.55% and a net margin of 7.57%. The business’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.76 EPS. Analysts predict that Church & Dwight Co., Inc. will post 3.16 EPS for the current fiscal year.

Church & Dwight Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Wednesday, November 15th will be paid a $0.2725 dividend. The ex-dividend date of this dividend is Tuesday, November 14th. This represents a $1.09 annualized dividend and a dividend yield of 1.18%. Church & Dwight’s dividend payout ratio (DPR) is currently 62.29%.

Church & Dwight Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.